Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)413.50
  • Today's Change-12.90 / -3.03%
  • Shares traded413.24k
  • 1 Year change+20.52%
  • Beta0.7631
Data delayed at least 15 minutes, as of Nov 12 2024 16:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,4032,3602,011
OPERATING EXPENSES
Cost of revenue total1,0981,072849
Selling, general and admin. expenses, total418402347
Depreciation/amortization667472
Unusual expense(income)65(50)(11)
Other operating expenses, total(11)(10)(8.88)
Total operating expense1,8691,7111,472
Operating income534649539
Other, net1114(1.08)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes525613528
Provision for income taxes117117105
Net income after taxes408496423
Minority interest(2.01)(1.34)0.13
Net income before extra. Items406494423
Total extraordinary items------
Net income406494423
Inc.avail. to common excl. extra. Items406494423
Inc.avail. to common incl. extra. Items406494423
EPS RECONCILIATION
Basic/primary weighted average shares277277278
Basic/primary eps excl. extra items1.471.791.52
Basic/primary eps incl. extra items1.471.791.52
Dilution adjustment------
Diluted weighted average shares278279280
Diluted eps excl. extra items1.461.771.51
Diluted eps incl. extra items1.461.771.51
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.830.810.74
Gross dividend - common stock0227205
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental217.936.99
SUPPLEMENTAL INCOME
Depreciation, supplemental162145154
Total special items65(50)(11)
NORMALISED INCOME
Normalized income before taxes590563517
Effect of special items on income taxes15(9.55)(2.14)
Income tax excluding impact of special items131107103
Normalized income after tax459455414
Normalized income avail. to common457454414
Basic normalized EPS1.651.641.49
Diluted normalized EPS1.641.631.48
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.